China Medical & HealthCare Group Limited provided consolidated earnings guidance for the eleven months ended 30 November 2022. For the period, the company group is expected to record a loss attributable to shareholders of the Company ("Net Loss") for the eleven months ended 30 November 2022 which represents (a) an approximately 26% decrease as compared with the Net Loss for the corresponding period in 2021; (b) an approximately 30% to 50% decrease when compared with the Net Loss for the year ended 31 December 2021; but (c) an approximately 20% to 40% increase when compared with the Net Loss for the year ended 31 December 2021 excluding the one-off non-recurring item of impairment loss under expected credit loss model recognized on loan receivable.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.69 HKD | 0.00% | 0.00% | -13.75% |
May. 20 | Tian an Medicare Limited Approves Final Dividend for the Year Ended 31 December 2023 | CI |
May. 02 | China Medical & HealthCare Changes Name to Tian An Medicare | MT |
1st Jan change | Capi. | |
---|---|---|
-13.75% | 95.97M | |
-29.52% | 14.76B | |
+3.48% | 11.75B | |
-7.21% | 11.48B | |
+8.23% | 10.76B | |
+27.94% | 8.6B | |
-7.18% | 7.45B | |
+8.01% | 6.84B | |
+9.84% | 6.48B | |
+16.78% | 4.47B |
- Stock Market
- Equities
- 383 Stock
- News Tian An Medicare Limited
- China Medical & Healthcare Group Limited Provides Consolidated Earnings Guidance for the Eleven Months Ended 30 November 2022